Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system

Stem Cells Translational Medicine

Volumn 4, Issue 2, 2015, Pages 195-206

  Peral, Susana Cantero ^a,b   Burkhart, Harold M ^a   Oommen, Saji ^a   Yamada, Satsuki ^a   Nyberg, Scott L ^a   Li, Xing ^a   O’Leary, Patrick W ^a   Terzic, Andre ^a   Cannon, Bryan C ^a   Nelson, Timothy J ^a,c  

^a MAYO CLINIC   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Autologous umbilical cord blood; Congenital heart disease; Intramyocardial delivery; Porcine; Right ventricle; Safety

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CELL THERAPY; CELL VIABILITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FLOW CYTOMETRY; HEART ELECTROPHYSIOLOGY; HISTOPATHOLOGY; MALE; MONONUCLEAR STEM CELL; NONHUMAN; THORACOTOMY; TISSUE REGENERATION; UMBILICAL CORD BLOOD; ALLOGRAFT; ANIMAL; CHILD; DISEASE MODEL; FETUS BLOOD; HEART; HEART DEFECTS, CONGENITAL; HUMAN; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PATHOPHYSIOLOGY; PERICARDIUM; PHYSIOLOGY; PIG; PRESCHOOL CHILD; REGENERATION; TRANSPLANTATION;

ANIMALIA; SUS;

ALLOGRAFTS; ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; FETAL BLOOD; HEART; HEART DEFECTS, CONGENITAL; HUMANS; LEUKOCYTES, MONONUCLEAR; PERICARDIUM; REGENERATION; SWINE;

EID: 84921734444     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0195     Document Type: Article

References (33)

1. Stamm C, Westphal B, Kleine H-D et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361:45-46.
2. Hendrikx M, Hensen K, Clijsters C et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006;114(suppl):I101-I107.
3. Pokushalov E, Romanov A, Chernyavsky A et al. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: A randomized study. J Cardiovasc Transl Res 2010;3: 160-168.
4. Ang K-L, Chin D, Leyva F et al. Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 2008;5: 663-670.
5. van Ramshorst J, Bax JJ, Beeres SL et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: A randomized controlled trial. JAMA 2009;301:1997- 2004.
6. Zhao Q, Sun Y, Xia L et al. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 2008;86:1833-1840.
7. Rupp S, Bauer J, Tonn T et al. Intracoronary administration of autologous bone marrowderived progenitor cells in a critically ill twoyr- old child with dilated cardiomyopathy. Pediatr Transplant 2009;13:620-623.
8. Rupp S, Jux C, Bönig H et al. Intracoronary bone marrow cell application for terminal heart failure in children. Cardiol Young 2012;22: 558-563.
9. Rupp S, Zeiher AM, Dimmeler S et al. A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrowderived progenitor cells. J Heart Lung Transplant 2010;29:574-577.
10. Harris DT, Rogers I. Umbilical cord blood: A unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007;2:301-309.
11. NiedaM, Nicol A, Denning-Kendall P et al. Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol 1997;98:775-777.
12. Pelosi E, Castelli G, Martin-Padura I et al. Human haemato-endothelial precursors: Cord blood CD34+ cells produce haemogenic endothelium. PLoS One 2012;7:e51109.
13. Gluckman E, Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-1178.
14. Henning RJ, Abu-Ali H, Balis JU et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 2004;13:729-739.
15. Henning RJ, Burgos JD, Ondrovic L et al. Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 2006;15:647-658.
16. Henning RJ, Burgos JD, VaskoMet al. Human cord blood cells and myocardial infarction: Effect of dose and route of administration on infarct size. Cell Transplant 2007;16:907-917.
17. Hirata Y, Sata M, Motomura N et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem Biophys Res Commun 2005;327:609-614.
18. Ma N, Stamm C, Kaminski A et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 2005;66:45-54.
19. Pinho-Ribeiro V, Maia AC, Werneck-de- Castro JP et al. Humanumbilical cord blood cells in infarcted rats. Braz J Med Biol Res 2010;43: 290-296.
20. Hu CH, Wu GF, Wang XQ et al. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med J (Engl) 2006;119:1499-1506.
21. Wu KH, Zhou B, Yu CT et al. Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg 2007;83:1491-1498.
22. Davies B, Elwood NJ, Li S et al. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training. Ann Thorac Surg 2010;89: 585-593.
23. Yerebakan C, Sandica E, Prietz S et al. Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload. Cell Transplant 2009; 18:855-868.
24. Donndorf P, Kundt G, Kaminski A et al. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: A meta-analysis. J Thorac Cardiovasc Surg 2011;142:911-920.
25. Wen Y, Meng L, Xie J et al. Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: A meta-analysis. Expert Opin Biol Ther 2011;11: 559-567.
26. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993;178:787-791.
27. Lu L, Xiao M, Shen RN et al. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993;81: 41-48.
28. Traycoff CM, Abboud MR, Laver J et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol 1994;22:215-222.
29. Laroche V, McKenna DH, Moroff G et al. Cell loss and recovery in umbilical cord blood processing:Acomparisonof postthawand postwash samples. Transfusion 2005;45:1909- 1916.
30. Huang L, Song G-Q, Wu Y et al. Optimal length of time of cryopreserved umbilical cord blood infusion after thawing. Hematology 2014;19:73-79.
31. Borenstein N, Jian Z, Fromont G et al. Noncultured cell transplantation in an ovine model of right ventricular preparation. J Thorac Cardiovasc Surg 2005;129:1119-1127.
32. Goodchild T, Pang W, Tondato F et al. Safety of intramyocardial injection of autologous bone marrow cells to treat myocardial ischemia in pigs. Cardiovasc Revasc Med 2006;7: 136-145.
33. Bhakta S, Greco NJ, Finney MR et al. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia. [published correction appears in J Invasive Cardiol 2006;18:297]. J Invasive Cardiol 2006;18:212-218.